
Saipen Pharmaceuticals Private Limited
About Saipen Pharmaceuticals Private Limited
Data last updated:
Saipen Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 23 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24231BR2011PTC017360.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sheo Shankar Gupta and Ajay Kumar.
Its last annual general meeting (AGM) was held on 10 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at C/O Ranu Sah Sanjay Nagar Road No. – 10 South Of Postal Park Gpo, Patna, Bihar, India – 800001.
As per the financials filed for FY 2019, the company reported a revenue of ₹3.57 Lakh, a growth of 84% compared to the previous year. For the same year it recorded a net loss of ₹5,702 (net margin -1.6%) and EBITDA of -₹3,164 (EBITDA margin -0.9%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Saipen Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Ranu Sah Sanjay Nagar Road No. – 10 South Of Postal Park Gpo, Patna, Bihar, India – 800001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Saipen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saipen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Saipen Pharmaceuticals Private Limited, buy the company report.
Financials of Saipen Pharmaceuticals Private Limited
FY 2019 filings availableSaipen Pharmaceuticals Private Limited reported revenue of ₹3.57 Lakh (up 84% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 84% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 22%. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,164 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,702 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saipen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Saipen Pharmaceuticals Private Limited
Saipen Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sheo Shankar Gupta | Director | 23 Aug 2011 | 15 Years 2 Months | Current |
| Ajay Kumar | Director | 23 Aug 2011 | 15 Years 2 Months | Current |
| Anu Kumari | Additional Director | 27 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
Saipen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shinehealth Pharmaceuticals Private Limited | ₹3.6 Lakh (FY 2022) | 55.0% | Ranchi, Jharkhand, India | |||
| Fertillmed Pharmaceuticals Private Limited | ₹3.58 Lakh (FY 2023) | -14.0% | Manjakkudi, Tamil Nadu, India | |||
| Saipen Pharmaceuticals Private Limitedthis company | ₹3.57 Lakh (FY 2019) | -₹5,702 | -1.6% | 84.0% | Patna, Bihar, India | |
| Shubhecha Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2023) | 1084.0% | Lucknow, Uttar Pradesh, India | |||
| Medanta Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2022) | -58.0% | Ahmedabad, Gujarat, India | |||
| Cress Pharmaceuticals Private Limited | ₹3.54 Lakh (FY 2024) | -45.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Saipen Pharmaceuticals Private Limited, buy the company report.
Auditor
Saipen Pharmaceuticals Private Limited is audited by D. JHA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. JHA & ASSOCIATES | FY 2017 | 08877C |
Shareholding
The shareholding of Saipen Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Saipen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saipen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saipen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Saipen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Saipen Pharmaceuticals Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Anu Kumari was appointed as Additional Director on 27 Apr 2013.
Frequently asked questions
Saipen Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 23 August 2011 (15+ years old) and is registered under CIN U24231BR2011PTC017360.
Saipen Pharmaceuticals has 3 current directors:
- Sheo Shankar Gupta - Director
- Ajay Kumar - Director
- Anu Kumari - Additional Director
The latest financial statements of Saipen Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 10 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Saipen Pharmaceuticals is U24231BR2011PTC017360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saipen Pharmaceuticals was incorporated on 23 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Saipen Pharmaceuticals by revenue are Shinehealth Pharmaceuticals Private Limited, Fertillmed Pharmaceuticals Private Limited, Shubhecha Pharmaceuticals Private Limited, Medanta Pharmaceuticals Private Limited, Cress Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anu Kumari was appointed as Additional Director on 27 Apr 2013. Ajay Kumar was appointed as Director on 23 Aug 2011. Sheo Shankar Gupta was appointed as Director on 23 Aug 2011.
The registered office of Saipen Pharmaceuticals is at CO Ranu Sah Sanjay Nagar Road No. – 10 South Of Postal Park Gpo, Patna, Bihar, India – 800001.
Saipen Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Saipen Pharmaceuticals is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Saipen Pharmaceuticals can be reached at its registered office: CO Ranu Sah Sanjay Nagar Road No. – 10 South Of Postal Park Gpo, Patna, Bihar, India – 800001.

